{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T06:04:13Z","timestamp":1789365853597,"version":"build-2803163510"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Frequent blood sampling in pediatric patients, particularly during hematopoietic stem cell transplantation (HSCT), can lead to significant cumulative blood loss and increase the risk of iatrogenic anemia. This study aimed to evaluate whether reducing the discard volume prior to blood sampling affects the accuracy of plasma Busulfan concentration measurements in this vulnerable population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and methods<\/jats:title>\n                    <jats:p>This prospective cohort study enrolled thirteen pediatric patients receiving HSCT at a tertiary children's hospital in China between July and October 2024. Blood samples were collected via double-lumen central venous catheters at seven time points (T0\u2013T6) after the fourth dose of Busulfan, using four different discard volumes (1, 2, 3, and 4\u2005mL). Each patient contributed repeated measurements under all four discard-volume conditions, resulting in 364 samples. Paired analyses were used to account for the within-patient repeated-measures design, and AUC non-inferiority was assessed against the prespecified 6% margin using the lower bound of the two-sided 95% confidence interval for the paired differences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Using paired within-patient analyses, no significant differences in plasma Busulfan concentrations were observed among the discard-volume conditions. Paired differences between reduced discard volumes (1, 2, and 3\u2005mL) and the 4\u2005mL reference remained small, with 95% confidence intervals demonstrating consistent agreement. AUC non-inferiority analysis showed that the reduced discard-volume approaches remained within the prespecified 6% non-inferiority margin. ICC demonstrated excellent agreement between the reduced discard-volume conditions and the 4\u2005mL reference for both individual time-point concentrations (ICC\u2009&amp;gt;\u20090.95) and AUC values. Bland\u2013Altman analysis showed consistent agreement, with differences evenly distributed within the calculated 95% limits of agreement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A minimal discard volume of 1\u2005mL demonstrated non-inferior accuracy compared with the standard 4\u2005mL discard volume for determining plasma Busulfan levels and overall drug exposure during therapeutic drug monitoring. Implementing this approach may reduce cumulative discarded blood volume by up to 21\u2005mL per patient during the seven sampling time points; however, the direct effect of reduced discard volume on anemia or transfusion requirements was not evaluated. This study adhered to the STROBE guidelines for observational research, and no patient or public contribution was involved.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1925821","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T05:38:57Z","timestamp":1789364337000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of minimum discard volume for central venous catheter sampling: Validation via busulfan therapeutic drug monitoring in pediatric transplant patients"],"prefix":"10.3389","volume":"14","author":[{"given":"Fang","family":"Ye","sequence":"first","affiliation":[{"name":"Department of Hematology and Oncology, Shenzhen Children's Hospital","place":["Shenzhen, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Shenzhen Children's Hospital","place":["Shenzhen, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongwei","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Shenzhen Children's Hospital","place":["Shenzhen, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanxuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Shenzhen Children's Hospital","place":["Shenzhen, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sailan","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Shenzhen Children's Hospital","place":["Shenzhen, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Shenzhen Children's Hospital","place":["Shenzhen, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandip","family":"Patil","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Shenzhen Children's Hospital","place":["Shenzhen, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.31547\/bct-2021-008","article-title":"Optimizing blood stem cell transplants through cellular engineering","volume":"5","author":"Soh","year":"2022","journal-title":"Blood Cell Ther"},{"key":"B2","doi-asserted-by":"publisher","first-page":"905879","DOI":"10.3389\/fphar.2022.905879","article-title":"The correlation between Busulfan exposure and clinical outcomes in Chinese pediatric patients: a population pharmacokinetic study","volume":"13","author":"Du","year":"2022","journal-title":"Front Pharmacol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e526","DOI":"10.1016\/S2352-3026(16)30114-4","article-title":"Association of Busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis","volume":"3","author":"Bartelink","year":"2016","journal-title":"Lancet Haematol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s40360-025-01015-w","article-title":"Therapeutic drug monitoring of Busulfan in pediatric patients: a 5-year observational study","volume":"26","author":"Alomari","year":"2025","journal-title":"BMC Pharmacol Toxicol"},{"key":"B5","year":"1999"},{"key":"B6","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/ajh.20900","article-title":"The accuracy of activated partial thromboplastin times when drawn through a peripherally inserted central catheter","volume":"82","author":"Rondina","year":"2007","journal-title":"Am J Hematol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/NAN.0000000000000396","article-title":"Infusion therapy standards of practice, 8th edition","volume":"44","author":"Gorski","year":"2021","journal-title":"J Infus Nurs"},{"key":"B8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1055\/s-0041-1726669","article-title":"Performance of 3\u2005mL versus 5\u2005mL discarded volume for blood sampling from central venous access device","volume":"13","author":"Lalthanthuami","year":"2021","journal-title":"J Lab Physicians"},{"key":"B9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.23736\/S0026-4806.18.05552-0","article-title":"Adoption and application in Italy of the principal guidelines and international recommendations on venous access","volume":"109","author":"Spina","year":"2018","journal-title":"Minerva Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1182\/blood-2012-03-417998","article-title":"A novel conditioning regimen improves outcomes in \u03b2-thalassemia major patients using unrelated donor peripheral blood stem cell transplantation","volume":"120","author":"Li","year":"2012","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1188\/12.CJON.454-458","article-title":"Determining the minimum discard volume for central venous catheter blood draws","volume":"16","author":"Wyant","year":"2012","journal-title":"Clin J Oncol Nurs"},{"key":"B12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1164\/rccm.200711-1637OC","article-title":"Anemia, blood loss, and blood transfusions in north American children in the intensive care unit","volume":"178","author":"Bateman","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/01.ftd.0000211810.19935.44","article-title":"Beyond cyclosporine: a systematic review of limited sampling strategies for other immunosuppressants","volume":"28","author":"Ting","year":"2006","journal-title":"Ther Drug Monit"},{"key":"B14","doi-asserted-by":"publisher","first-page":"226","DOI":"10.2146\/ajhp070054","article-title":"Misleading tacrolimus concentration value in blood taken from a catheter used for tacrolimus administration","volume":"65","author":"Grouzmann","year":"2008","journal-title":"Am J Health Syst Pharm"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1177\/08971900221107841","article-title":"Artificially elevated tacrolimus concentrations obtained from a venous catheter previously used for tacrolimus administration in a pediatric patient","volume":"36","author":"Marschner","year":"2023","journal-title":"J Pharm Pract"},{"key":"B16","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"Von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1182\/bloodadvances.2025019142","article-title":"Refining Busulfan exposure enhances pediatric ALL HSCT outcomes: insights from the international FORUM study","volume":"10","author":"Ben Hassine","year":"2026","journal-title":"Blood Adv"},{"key":"B18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.4266\/acc.000792","article-title":"Minimizing discard volume to 2\u2005mL before blood sampling from a central venous catheter: a prospective observational study in India","volume":"41","author":"Pushparaj","year":"2026","journal-title":"Acute Crit Care"},{"key":"B19","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/nicc.12220","article-title":"Reliability of blood test results in samples obtained using a 2-mL discard volume from the proximal lumen of a triple-lumen central venous catheter in the critically ill patient","volume":"22","author":"Villalta-Garc\u00eda","year":"2017","journal-title":"Nurs Crit Care"},{"key":"B20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.enfie.2022.06.002","article-title":"Is minimising waste volume for drawing blood samples in critically ill patients feasible?","volume":"34","author":"Castro-Olmo","year":"2023","journal-title":"Enferm Intensiva (Engl Ed)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/NAN.0000000000000532","article-title":"Infusion therapy standards of practice, 9th edition","volume":"47","author":"Nickel","year":"2024","journal-title":"J Infus Nurs"},{"key":"B22","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1592\/phco.31.8.776","article-title":"A reliable and safe method of collecting blood samples from implantable central venous catheters for determination of plasma gentamicin concentrations","volume":"31","author":"Chen","year":"2011","journal-title":"Pharmacotherapy"},{"key":"B23","doi-asserted-by":"publisher","first-page":"E55","DOI":"10.1097\/NCC.0000000000000544","article-title":"Serum cyclosporine levels: the influence of the time interval between interrupting the infusion and obtaining the samples: a randomized clinical trial","volume":"41","author":"Garbin","year":"2018","journal-title":"Cancer Nurs"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1925821\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T05:38:58Z","timestamp":1789364338000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1925821\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":23,"alternative-id":["10.3389\/fped.2026.1925821"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1925821","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"article-number":"1925821"}}